AI assistant
Inogen Inc — Director's Dealing 2023
Dec 5, 2023
33625_dirs_2023-12-04_8acc1df0-5717-4854-8c22-cc694683aa7b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2023-12-01
Reporting Person: Somer Jason (EVP, Gen. Counsel & Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-12-01 | Common Stock | M | 576 | $0.00 | Acquired | 4200 | Direct |
| 2023-12-01 | Common Stock | F | 286 | $5.72 | Disposed | 3914 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-12-01 | Restricted Stock Unit | $ | M | 576 | Disposed | Common Stock (576) | Direct |
Footnotes
F1: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted
stock award that vested on December 1, 2023.
F2: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F3: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.